Dual small molecule inhibitors of cancer and angiogenesis
US8642610B2 · kind B2 · utility
5Cited by
10References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 6, 2012 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Feb 6, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides analogs and derivatives of thalidomide which inhibit cancer and angiogenesis. The present invention further provides compounds which disrupt microtubule polymerization. The present further provides methods of treating cancers comprising mutant p53.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.